ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
ICON plc today announced that all resolutions at the Annual General Meeting of the Company (AGM) held on July 26, 2022 (which resolutions had all been recommended by the Board) were all duly passed by shareholders.
ICON Reports Second Quarter 2022 Results
Quarter 2 revenue of $1,935.2 million representing a year on year increase of 122.1%.
ICON establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses
ICON establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses.
ICON plc schedules second quarter 2022 earnings conference call
ICON plc schedules second quarter 2022 earnings conference call on Wednesday, July 27, 2022
ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference
Tuesday, May 24, 2022, at 7:00am ET.
ICON named Business & Finance Company of the Year and one of Forbes’ Best Employers for Diversity
ICON kick starts the first half of 2022 with a string of prestigious industry awards recognising healthcare intelligence work and staff, as independently judged by peers worldwide
ICON plc to present at the BofA Securities 2022 Healthcare Conference
Tuesday, May 10, 2022, at 5:20pm PT.
ICON reports first quarter 2022 results
Quarter 1 adjusted revenue of $1.901.8 million representing a year on year increase of 121.6% or 125% on a constant currency basis.
ICON plc to Webcast Analyst Day Meeting
Thursday, March 17, 2022 at 12:30 ET.
ICON Reports Fourth Quarter and Full Year 2021 Results
Record net business wins in the quarter of $2,378 million; a net book to bill of 1.26. Full year net business wins of $6,958 million; a net book to bill of 1.27.